IRCCS San Raffaele: Pancreatic Neoplasms trials
The registry lists 20 Pancreatic Neoplasms studies with IRCCS San Raffaele as lead sponsor. 11 are open to participants now and 0 have results posted.
Phase 2 7Phase 3 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic CancerNot yet recruitingNCT07803770
- Pancreatic Cancer Lifestyle Evolution And ResistanceNot yet recruitingNCT07794969
- Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas UnitsNot yet recruitingNCT07418164
- Feasibility and Effectiveness of Three-day Discharge After Distal PancreatectomyNot yet recruitingNCT07095621
- Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the PancreasRecruitingNCT06706700
- Iconographic Registry of Pancreatobiliary Endoscopy ProceduresRecruitingNCT06344507
- 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine TumoursRecruitingNCT06155318
- Management of Malignant Gastric Outlet Obstruction Between Surgery and EndoscopyRecruitingNCT06071507
- Prehabilitation in Pancreatic SurgeryRecruitingNCT06069297Not applicable
- Radiology Registry on Pancreatic MalignanciesRecruitingNCT05714111
- Pancreatic Cancer Evolution Upon TreatmentRecruitingNCT05195281Not applicable
- EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer PatientsCompletedNCT05247164Not applicable
- COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncerCompletedNCT04257955
- Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line ChemotherapyCompletedNCT01339754Phase 2
- Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT01167738Phase 2
- Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic CancerCompletedNCT01150630Phase 2
- Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerCompletedNCT00967603Phase 2
- Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00967291Phase 2
- Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic CancerCompletedNCT00966706Phase 2
- Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic CancerCompletedNCT00960284Phase 2/3